Clinical trial
Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the…
NCT00054457 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00054457 |
|---|---|
| Title | Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction |
| Official title | A Phase II Study Of Docetaxel And Capecitabine In Patients With Measurable Metastatic Adenocarcinoma Of The Stomach And Gastroesophageal Junction |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, docetaxel |
| Enrollment | 46 |
| Start date | Sep 1, 2003 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Feb 6, 2003 |
| Last update posted | Dec 13, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: